Drug intelligence / Profile preview

maltodextrin + caffeine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Maltodextrin + caffeine is a combination product typically used as a dietary supplement or as part of sports and cognitive performance products. Caffeine is a central nervous system stimulant of the methylxanthine class, acting primarily as a non-selective adenosine receptor antagonist, with additional effects on phosphodiesterase inhibition and catecholamine release, leading to increased alertness, enhanced exercise performance, and cognitive effects[2][3][5]. Maltodextrin is a polysaccharide carbohydrate, easily digestible and commonly used as a food additive for energy replenishment, with no known direct pharmacological activity but potentially able to affect brain reward pathways via oral sensing and rapid glucose availability[4][1][3][5]. The combination has been studied in the context of mouth rinses and ingestion for reduction of cognitive fatigue and improved exercise performance[1][3][5].

02

Targets

ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)TAS1R3 (Sweet taste receptor T1R3 subunit)PDE (Phosphodiesterase family)ADOR (Adenosine receptors)

Beyond the preview

Go deeper on maltodextrin + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on maltodextrin + caffeine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call